Home
>
National Drug Code (NDC)
>
EDURANT
EDURANT - 59676-278-01 - (rilpivirine hydrochloride)
Drug Information of EDURANT
| Product NDC: | 59676-278 |
| Proprietary Name: | EDURANT |
| Non Proprietary Name: | rilpivirine hydrochloride |
| Active Ingredient(s): | 25 mg/1 & nbsp; rilpivirine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of EDURANT
| Product NDC: | 59676-278 |
| Labeler Name: | Janssen Products, LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202022 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110520 |
Package Information of EDURANT
| Package NDC: | 59676-278-01 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (59676-278-01) |
NDC Information of EDURANT
| NDC Code | 59676-278-01 |
| Proprietary Name | EDURANT |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (59676-278-01) |
| Product NDC | 59676-278 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rilpivirine hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20110520 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Products, LP |
| Substance Name | RILPIVIRINE HYDROCHLORIDE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Non-Nucleoside Analog [Chemical/Ingredient] |
